Azpiri-Lopez Jose R, Galarza-Delgado Dionicio A, Garza-Cisneros Andrea N, Guajardo-Jauregui Natalia, Balderas-Palacios Mario A, Garcia-Heredia Alexis, Cardenas-de la Garza Jesus A, Rodriguez-Romero Alejandra B, Reyna-de la Garza Roberto A, Azpiri-Diaz Hernan, Alonso-Cepeda Othon, Colunga-Pedraza Iris J
Cardiology Service, Internal Medicine Department, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", 103564Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
Rheumatology Service, Internal Medicine Department, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", 103564Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
Lupus. 2022 Aug;31(9):1127-1131. doi: 10.1177/09612033221106581. Epub 2022 Jun 1.
We aimed to compare the prevalence of subclinical left ventricular systolic dysfunction in Hispanic systemic lupus erythematosus (SLE) patients versus healthy controls.
This cross-sectional study included 46 SLE patients who fulfilled the 2019 European League Against Rheumatism and American College of Rheumatology (EULAR/ACR) classification criteria for SLE and with age ≥ 18 years. For comparison, we included a control group with 46 non-SLE subjects matched by age (±5 years) and gender. A transthoracic echocardiogram was performed on every participant. The echocardiographic measurements evaluated were left ventricular ejection fraction (LVEF), relative wall thickness (RWT), and tricuspid annular plane systolic excursion (TAPSE). Left ventricular-Global Longitudinal Strain (GLS) was evaluated, and a value higher than -18% was classified as subclinical left ventricular systolic dysfunction. Comparisons between groups were made using the Chi-square test or Fisher's exact test for qualitative variables, and Student's t-test or the Mann-Whitney's U test for quantitative variables. A p-value <.05 was considered significant.
We found a significant difference in the presence of subclinical left ventricular systolic dysfunction between SLE-patients and controls (37.0% vs 8.7%, = .001). We also found that SLE patients had a lower left ventricular GLS (-18.90% vs -20.51%, = .011), TAPSE (21.63 mm vs 23.60 mm, = .009), and LVEF (57.17% vs 62.47%, = <.001) than controls. Systemic lupus erythematosus diagnosis was independently associated with the presence of subclinical left ventricular systolic dysfunction with an OR of 6.068 (CI 95% 1.675-21.987) ( = .006). Subclinical systolic dysfunction was more common in men (29.4% vs 3.4%, = .020), patients with obesity (17.6% vs 0%, = .045), or hypertension (47.1% vs 6.9%, = .001).
Systemic lupus erythematosus Hispanic patients had a higher prevalence of subclinical left ventricular systolic dysfunction, and worse left ventricular GLS, LVEF, and TAPSE values than matched healthy controls. Additionally, we found that male gender, obesity, and hypertension are associated with the presence of subclinical left ventricular systolic dysfunction in SLE patients. The inclusion of speckle tracking echocardiography as part of the cardiovascular evaluation of SLE patients may help identify high cardiovascular risk patients.
我们旨在比较西班牙裔系统性红斑狼疮(SLE)患者与健康对照者中亚临床左心室收缩功能障碍的患病率。
这项横断面研究纳入了46例符合2019年欧洲抗风湿病联盟和美国风湿病学会(EULAR/ACR)SLE分类标准且年龄≥18岁的SLE患者。为作比较,我们纳入了一个由46名非SLE受试者组成的对照组,这些受试者在年龄(±5岁)和性别上进行了匹配。对每位参与者进行了经胸超声心动图检查。评估的超声心动图测量指标包括左心室射血分数(LVEF)、相对室壁厚度(RWT)和三尖瓣环平面收缩期位移(TAPSE)。评估了左心室整体纵向应变(GLS),GLS值高于-18%被分类为亚临床左心室收缩功能障碍。使用卡方检验或Fisher精确检验对定性变量进行组间比较,使用学生t检验或Mann-Whitney U检验对定量变量进行组间比较。p值<.05被认为具有统计学意义。
我们发现SLE患者和对照组之间亚临床左心室收缩功能障碍的存在有显著差异(37.0%对8.7%,p =.001)。我们还发现SLE患者的左心室GLS较低(-18.90%对-20.51%,p =.011),TAPSE较低(21.63mm对23.60mm,p =.009),LVEF也较低(57.17%对62.47%,p <.001)。SLE诊断与亚临床左心室收缩功能障碍的存在独立相关,比值比为6.068(95%置信区间1.675 - 21.987)(p =.006)。亚临床收缩功能障碍在男性中更常见(29.4%对3.4%,p =.020),在肥胖患者中更常见(17.6%对0%,p =.045),或在高血压患者中更常见(47.1%对6.9%,p =.001)。
西班牙裔SLE患者中亚临床左心室收缩功能障碍的患病率较高,且左心室GLS、LVEF和TAPSE值比匹配的健康对照者更差。此外,我们发现男性、肥胖和高血压与SLE患者中亚临床左心室收缩功能障碍的存在有关。将斑点追踪超声心动图纳入SLE患者的心血管评估可能有助于识别心血管高风险患者。